Home > Insider Trading > Filing (0001628280-25-032626)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1894562	Prime Medicine Inc.	PRME	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664439	R. David Liu	C/O Prime Medicine, Inc. 60 First Street Cambridge MA 02141		No	No	Yes	No

Transaction Summary

Purchased:	21,000 shares	Avg. Price: $2.16	Total Value: $45,402.00
Number of Shares After Transactions:	20,219,945 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-23	21,000	$2.16	20,219,945	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.
The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.